Literature DB >> 10066094

Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1.

R J Bohinski1, P A Bejarano, G Balko, R E Warnick, J A Whitsett.   

Abstract

Determining the primary site of a cerebral metastatic adenocarcinoma is complicated by the histologic similarity of most adenocarcinomas. Thyroid Transcription Factor-1 (TTF-1) is a highly specific marker of peripheral airway cell neoplasms. Formalin fixed tissue from 30 patients with brain metastasis whose primary sources were clinically and histologically known with certainty were analyzed for immunoreactivity to TTF-1. There were 18 cases of metastatic lung adenocarcinoma. Other metastases were from breast (6), colon (1), prostate (1), kidney (1), paranasal sinus (1), melanoma (1), and intestinal carcinoid (1). No patients with carcinoma of the thyroid were found. Positivity was regarded as intense nuclear reactivity. Twelve (67%) metastatic lung adenocarcinomas stained for TTF-1. None of the cerebral metastases from other body sites showed positivity. In addition, normal brain tissue and astrocytic tumors did not stain for TTF-1. These data show that TTF-1 is a highly specific and reasonably sensitive marker for peripheral airway cell metastasis to the brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10066094     DOI: 10.1023/a:1006102607697

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Management of patients with brain metastases of unknown origin.

Authors:  M Debevec
Journal:  Neoplasma       Date:  1990       Impact factor: 2.575

2.  The contribution of immunohistochemical staining in tumour diagnosis.

Authors:  A S Leong; J Wright
Journal:  Histopathology       Date:  1987-12       Impact factor: 5.087

3.  Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis.

Authors:  A Holzinger; S Dingle; P A Bejarano; M A Miller; T E Weaver; R DiLauro; J A Whitsett
Journal:  Hybridoma       Date:  1996-02

4.  Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases.

Authors:  T Le Chevalier; F P Smith; P Caille; J P Constans; J G Rouesse
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

5.  Brain metastases. Histology, multiplicity, surgery, and survival.

Authors:  E S Nussbaum; H R Djalilian; K H Cho; W A Hall
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

6.  Adenocarcinoma in the lung in patients with breast cancer. A prospective analysis of the discriminatory value of immunohistology.

Authors:  S S Raab; L C Berg; P E Swanson; M R Wick
Journal:  Am J Clin Pathol       Date:  1993-07       Impact factor: 2.493

7.  Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated?

Authors:  M van de Pol; V C van Aalst; J T Wilmink; A Twijnstra
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

8.  The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis.

Authors:  R J Bohinski; R Di Lauro; J A Whitsett
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

9.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07

10.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.

Authors:  D Lazzaro; M Price; M de Felice; R Di Lauro
Journal:  Development       Date:  1991-12       Impact factor: 6.868

View more
  8 in total

1.  The war on cancer: a report from the front lines.

Authors:  Gavin Melmed
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-10

2.  The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.

Authors:  Yunfan Ma; Mengying Fan; Liang Dai; Xiaozheng Kang; Yiqiang Liu; Yu Sun; Wanpu Yan; Zhen Liang; Hongchao Xiong; Keneng Chen
Journal:  Tumour Biol       Date:  2015-05-16

3.  Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

Authors:  Dongfeng Tan; Dani S Zander
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 4.  Nkx2-1: a novel tumor biomarker of lung cancer.

Authors:  Li Yang; Min Lin; Wen-jing Ruan; Liang-liang Dong; En-guo Chen; Xiao-hong Wu; Ke-jing Ying
Journal:  J Zhejiang Univ Sci B       Date:  2012-11       Impact factor: 3.066

5.  Single brain metastases of carcinoid tumors.

Authors:  Francesco Maiuri; Paolo Cappabianca; Marialaura Del Basso De Caro; Felice Esposito
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

6.  Peroperative frozen section analysis of TTF-1 antigen expression.

Authors:  S Camilleri-Broet; M Alifano; M Morcos; E Comperat; P Magdeleinat; B Marmey; T J Molina; J-F Régnard; J Audouin
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

7.  Expression of secretoglobin3A2 (SCGB3A2) in primary pulmonary carcinomas.

Authors:  Motoko Tachihara-Yoshikawa; Takashi Ishida; Kana Watanabe; Aya Sugawara; Kenya Kanazawa; Ryuzo Kanno; Toshimitsu Suzuki; Tomoaki Niimi; Shioko Kimura; Mitsuru Munakata
Journal:  Fukushima J Med Sci       Date:  2008-12

8.  Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Authors:  G Stenhouse; N Fyfe; G King; A Chapman; K M Kerr
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.